LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,798 | -98.0% | 30 | -97.6% | 0.00% | -98.5% |
| Q2 2023 | $91,639 | +8208.2% | 1,271 | +8373.3% | 0.07% | +6600.0% |
| Q1 2023 | $1,103 | -98.3% | 15 | -97.8% | 0.00% | -98.4% |
| Q3 2020 | $66,000 | -77.9% | 693 | -74.0% | 0.06% | -77.7% |
| Q2 2020 | $299,000 | +116.7% | 2,670 | +143.8% | 0.27% | +97.8% |
| Q1 2019 | $138,000 | +97.1% | 1,095 | +329.4% | 0.14% | +109.1% |
| Q3 2018 | $70,000 | +29.6% | 255 | -1.9% | 0.07% | +32.0% |
| Q2 2018 | $54,000 | +25.6% | 260 | 0.0% | 0.05% | +28.2% |
| Q1 2018 | $43,000 | – | 260 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |